(2023). Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life‑Threatening COVID‑19 Pneumonia.
Chicago Style (17th ed.) CitationAutoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life‑Threatening COVID‑19 Pneumonia. 2023.
MLA (8th ed.) CitationAutoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life‑Threatening COVID‑19 Pneumonia. 2023.
Warning: These citations may not always be 100% accurate.
